Haunted manuscripts: Ghost authorshipin the medical literature

Accountability in Research

Volumn 12, Issue 2, 2005, Pages 103-114

  Ngai, Stephanie ^a   Gold, Jennifer L ^a,b   Gill, Sudeep S ^a,c,d   Rochon, Paula A ^a,d,e  

^a Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONFLICT OF INTEREST; ETHICS; FINANCIAL MANAGEMENT; FORGERY; HUMAN; INDUSTRY; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; PUBLICATION; PUBLISHING; RECUMBENCY; SCIENTIFIC MISCONDUCT; SOCIAL BEHAVIOR; STANDARD; WRITING;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AUTHORSHIP; CLINICAL TRIALS; CONFLICT OF INTEREST; DECEPTION; DISCLOSURE; FRAUD; HUMANS; INDUSTRY; INTERNATIONALITY; PERIODICALS; PUBLISHING; RESEARCH SUPPORT; SCIENTIFIC MISCONDUCT; SOCIAL RESPONSIBILITY; WRITING;

EID: 32944465880     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620590957175     Document Type: Article

References (24)

1. Bennett, D.M., and Taylor, D. (2003). Unethical Practices in Authorship ofScientific Papers, Emergency Medicine, 15: 263-270.
2. Bevan, J.C. (2002). Ethical Behaviour of Authors in Biomedical Journals, Annalsof the Royal College of Physicians and Surgeons of Canada, 35(2): 81-85.
3. Bhopal, R., Rankin, J., McColl, E., Thomas, L., Kaner, E., Stacy, R., et al. (1997). The Vexed Question of Authorship: Views of Researchers in a British MedicalFaculty, BMJ, 314: 1009-1012.
4. Brennan, T.A. (1994). Buying Editorials, New England Journal of Medicine, 331:673-675.
5. Chaudhry, S., Schroter, S., Smith, R., and Morris, J. (2002). Does Declaration ofCompeting Interests Affect Readers' Perceptions? A Randomized Trial, BMJ, 325: 1391-1392.
6. Davidoff, F., DeAngelis, C.D., Drazen, J.M., Hoey, J.H., Hojgaard, L., Horton, R., et al. (2001). Sponsorship, Authorship, and Accountability, Annals of InternalMedicine, 135: 463.
7. Flanagin, A., Carey, L.A., Fontanarosa, P.B., Phillips, S.G., Pace, B.P., Lundberg, G.D., et al. (1998). Prevalence of Articles with Honorary Authors and GhostAuthors in Peer-Reviewed Medical Journals, JAMA, 280: 222-224.
8. Hong, M.-K., and Bero, L. (2002). How the Tobacco Industry Responded to anInfluential Study of the Health Effects of Secondhand Smoke, BMJ, 325:1413-1416
9. International Committee of Medical Journal Editors. (2001). Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Updated October2001. Available at www.icmje.org/. Accessed on June 16, 2004.
10. Jewesson, P. (2003). Ghostwriters in the Sky, Journal of Informed Pharmacotherapy, 13: 1-4.
11. Larkin, M. (1999). Whose Article Is It Anyway? Lancet, 354: 136.
12. Levy, D. (1996). Ghostwriters a Hidden Resource for Drug Makers, USA Today (September 25). Accessed online using Lexis-Nexis.
13. Lexchin, J., Bero, L., Djulbegovic, B., and Clark, O. (2003).PharmaceuticalIndustry Sponsorship and Research Outcome and Quality: SystematicReview, BMJ, 326: 1167-1170.
14. Mowatt, G., Shirran, L., Grimshaw, J.M., Rennie, D., Flanagin, A., Yank, V., et al. (2002). Prevalence of Honorary and Ghost Authorship in Cochrane Reviews,JAMA, 287: 2769-2771.
15. Price, J.H., Dake, J.A., and Oden, L. (2000). Authorship of Health EducationArticles: Guests, Ghosts, and Trends, American Journal of Health Behavior, 24:290-299.
16. Rennie, D., and Flanagin, A. (1994). Authorship! Guests, Ghosts, Grafters, andthe Two-Sided Coin, JAMA, 271: 469-471.
17. Rennie, D., Yank, V., and Emanuel, L. (1997). When Authorship Fails: A Proposal to Make Contributors Accountable, JAMA, 278: 579-585
18. Rennie, D., Flanagin, A., and Yank, V. (2000). The Contributions of Authors, JAMA, 284: 89-91.
19. Riis, P. (2000). Scientific Dishonesty: European Reflections, Journal of Clinical Pathology, 54: 4-6.
20. Rochon, P.A., Gurwitz, J.H., Simms, R.W., Fortin, P.R., Felson, D.T., Minaker, K.L., and Chalmers, T.C. (1994). A Study of Manufacturer-Supported Trialsof Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Arthritis,Archives of Internal Medicine, 154: 157-163.
21. Smith, R. (2001). Meeting Calls for a National Body to Respond to ResearchMisconduct, BMJ, 323: 889.
22. U.S. Food and Drug Administration. (1997). Questions and Answers AboutWithdrawal of Fenfluramine (Pondimin) and Dexfenfluramine (Redux). Available at http://www.fda.gov/cder/news/phen/fenphenqa2.htm Accessedon June 16, 2004.
23. Wazana, A. (2000). Physicians and the Pharmaceutical Industry: Is a Gift EverJust a Gift? JAMA, 283: 373-380.
24. Yank, V., and Rennie, D. (1999). Disclosure of Researcher Contributions: A Study of Original Research Articles in The Lancet. Published in Annals ofInternal Medicine, 130: 661-670.